Skip to main content

Features

New Drugs for Lou Gehrig's Disease Head for Clinical Trials

Newly discovered genetic mutations are providing clues about how this disorder relentlessly destroys motor neurons and robs people of their mobility. The findings may lead to drug therapies for a condition that has long defied treatment

By Leonard Petrucelli and Aaron D. Gitler

Online Exclusives

Departments

Purchase To Read More

Already purchased this issue? Sign In to Access
Select Format

Memorial Day Sale

20% Off Sitewide